Evolus logo
Evolus
EOLS | NASDAQ
Chart Builder DCF Calculator
$6.63
-$0.33 (-4.74%)
At close: Nov 16, 2026, 4:00 PM ET
$6.63
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Evolus Company Profile

Company profile explained

Company Profile

Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.

Key Executives

Name Position
David Moatazedi President, Chief Executive Officer & Director
Tatjana Mitchell Chief Financial Officer
Jeffrey J. Plumer Corporate Secretary
Jessica Novak Senior Vice President of Human Resources
Kurt Knab Senior Vice President of Sales
Nareg Sagherian Head of Global Investor Relations & Corporate Communications
Rui Avelar C.CFP Dip.SportMed Chief Medical Officer and Head of Research & Development

Latest SEC Filings

Date Type Title
Sep 04, 2026 4 Filing
Aug 31, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 05, 2026 10-Q Quarterly Report
Aug 05, 2026 8-K Current Report
Aug 04, 2026 8-K Current Report
Jul 08, 2026 8-K Current Report
Jun 12, 2026 EFFECT Filing
Jun 12, 2026 8-K Current Report
Jun 05, 2026 S-3 Filing
May 04, 2026 10-Q Quarterly Report
View All SEC Filings ➞
Evolus
Evolus logo
Country United States
IPO Date Feb 8, 2018
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 353
CEO David Moatazedi

Contact Details

520 Newport Center Drive Newport Beach, California 92660 United States

Stock Details

Ticker Symbol EOLS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001570562
CUSIP Number 30052C107
ISIN Number US30052C1071
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.